These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27909475)

  • 41. [Percutaneous closure of the left atrial appendage for stroke prevention].
    Loupis AM; De Backer O; Ihlemann N; Rosenberg TS; Franzen OW; Søndergaard L
    Ugeskr Laeger; 2014 Sep; 176(38):. PubMed ID: 25294196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Watchman Device: Left Atrial Appendage Closure For Stroke Prophylaxis In Atrial Fibrillation.
    N Obeyesekere Mbbs Mrcp Fracp Fhrs DM
    J Atr Fibrillation; 2014; 7(2):1099. PubMed ID: 27957099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device.
    Alipour A; Wintgens LI; Swaans MJ; Balt JC; Rensing BJ; Boersma LV
    Vasc Health Risk Manag; 2017; 13():81-90. PubMed ID: 28293114
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Catheter Ablation for Atrial Fibrillation in Patients With Watchman Left Atrial Appendage Occlusion Device: Results from a Multicenter Registry.
    Turagam MK; Lavu M; Afzal MR; Vuddanda V; Jazayeri MA; Parikh V; Atkins D; Bommana S; DI Biase L; Horton R; Bai R; Swarup V; Cheng J; Natale A; Lakkireddy D
    J Cardiovasc Electrophysiol; 2017 Feb; 28(2):139-146. PubMed ID: 27943538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonpharmacologic approaches to stroke prevention in atrial fibrillation.
    Whitlock RP; Hanif H; Danter M
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S79-86. PubMed ID: 23790602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preliminary findings on left atrial appendage occlusion simulations applying different endocardial devices.
    D'Alessandro N; Falanga M; Masci A; Severi S; Corsi C
    Front Cardiovasc Med; 2023; 10():1067964. PubMed ID: 36891242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Percutaneous left atrial appendage occlusion in atrial fibrillation patients with a contraindication to oral anticoagulation: a focused review.
    Nishimura M; Sab S; Reeves RR; Hsu JC
    Europace; 2018 Sep; 20(9):1412-1419. PubMed ID: 29228158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does left atrial appendage closure with a cardiac plug system reduce the stroke risk in nonvalvular atrial fibrillation patients? A single-center case series.
    Danna P; Proietti R; Sagone A; Arensi A; Viecca M; Rago A; Russo V
    Pacing Clin Electrophysiol; 2013 Mar; 36(3):347-53. PubMed ID: 23252940
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Left atrial appendage closure for "primary primary" prevention during percutaneous closure of septal defects in patients with large atria but no atrial fibrillation.
    Kuwata S; Vierecke J; Gloekler S; Maisano F; Meier B; Nietlispach F
    Cardiol J; 2018; 25(2):179-187. PubMed ID: 28840592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Percutaneous left atrial appendage closure-An alternative strategy for anticoagulation in atrial fibrillation and hereditary hemorrhagic telangiectasia?
    Vorselaars VM; Velthuis S; Swaans MJ; Mager JJ; Snijder RJ; Rensing BJ; Boersma LV; Post MC
    Cardiovasc Diagn Ther; 2015 Feb; 5(1):49-53. PubMed ID: 25774347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Left atrial appendage occlusion in high-risk patients with non-valvular atrial fibrillation.
    Berti S; Pastormerlo LE; Rezzaghi M; Trianni G; Paradossi U; Cerone E; Ravani M; De Caterina AR; Rizza A; Palmieri C
    Heart; 2016 Dec; 102(24):1969-1973. PubMed ID: 27492943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
    Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimal combination strategy of left atrial appendage closure plus catheter ablation in a single procedure in patients with nonvalvular atrial fibrillation.
    Du X; Chu H; He B; Wang B; Liu J; Feng M; Yu Y; Fu G; Jin H; Gao F; Zhu J; Chen X
    J Cardiovasc Electrophysiol; 2018 Aug; 29(8):1089-1095. PubMed ID: 29727507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus document: Percutaneous left atrial appendage occlusion in patients with nonvalvular atrial fibrillation: indications, patient selection, competences, organization, and operator training].
    Casu G; Gulizia MM; Molon G; Mazzone P; Audo A; Casolo G; Di Lorenzo E; Portoghese M; Pristipino C; Ricci RP; Themistoclakis S; Padeletti L; Tondo C; Berti S; Oreglia JA; Gerosa G; Zanobini M; Ussia GP; Musumeci G; Romeo F; Di Bartolomeo R
    G Ital Cardiol (Rome); 2016; 17(7-8):594-613. PubMed ID: 27571335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [New technology for prevention of embolic events in atrial fibrillation: a systematic review on percutaneous endovascular left atrial appendage closure].
    Danna P; Sagone A; Proietti R; Arensi A; Viecca M; Santangeli P; Di Biase L; Natale A
    G Ital Cardiol (Rome); 2012 Sep; 13(9):571-82. PubMed ID: 22825342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Left atrial appendage occlusion: rationale, evidence, devices, and patient selection.
    Piccini JP; Sievert H; Patel MR
    Eur Heart J; 2017 Mar; 38(12):869-876. PubMed ID: 27628431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation.
    Massumi A; Chelu MG; Nazeri A; May SA; Afshar-Kharaghan H; Saeed M; Razavi M; Rasekh A
    Am J Cardiol; 2013 Mar; 111(6):869-73. PubMed ID: 23312129
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Combined left atrial appendage percutaneous closure and atrial fibrillation ablation: a single center experience].
    Pelissero E; Giuggia M; Todaro MC; Trapani G; Giordano B; Senatore G
    G Ital Cardiol (Rome); 2017 Dec; 18(12 Suppl 1):11S-17S. PubMed ID: 29297907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Left atrial appendage morphology and thromboembolic risk after catheter ablation for atrial fibrillation.
    Nedios S; Kornej J; Koutalas E; Bertagnolli L; Kosiuk J; Rolf S; Arya A; Sommer P; Husser D; Hindricks G; Bollmann A
    Heart Rhythm; 2014 Dec; 11(12):2239-46. PubMed ID: 25128733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.